1. Home
  2. MED vs ACOG Comparison

MED vs ACOG Comparison

Compare MED & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MEDIFAST INC

MED

MEDIFAST INC

HOLD

Current Price

$10.90

Market Cap

120.6M

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.91

Market Cap

110.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
MED
ACOG
Founded
1980
2000
Country
United States
Canada
Employees
N/A
57
Industry
Packaged Foods
Sector
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
120.6M
110.4M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
MED
ACOG
Price
$10.90
$5.91
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$12.00
$16.00
AVG Volume (30 Days)
183.5K
72.4K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$934,842,000.00
N/A
Revenue This Year
N/A
$139.22
Revenue Next Year
N/A
$134.48
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.22
$4.50
52 Week High
$15.37
$10.88

Technical Indicators

Market Signals
Indicator
MED
ACOG
Relative Strength Index (RSI) 55.43 41.16
Support Level $10.14 $5.74
Resistance Level $10.87 $6.59
Average True Range (ATR) 0.29 0.47
MACD 0.01 -0.09
Stochastic Oscillator 73.11 7.00

Price Performance

Historical Comparison
MED
ACOG

About MED MEDIFAST INC

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: